Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality
Policy / Regulatory

NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality

June 25, 2025
Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services
CompanyDeals

Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services

June 25, 2025
Lundbeck's Lu AG13909 Wins Orphan Drug Designations for Congenital Adrenal Hyperplasia
CompanyDrug

Lundbeck’s Lu AG13909 Wins Orphan Drug Designations for Congenital Adrenal Hyperplasia

June 25, 2025
Henlius Biotech Doses First Patient in Japanese Bridging Trial of Serplulimab for ES-SCLC
CompanyDrug

Henlius Biotech Doses First Patient in Japanese Bridging Trial of Serplulimab for ES-SCLC

June 25, 2025
C.Q. Pharma's Prasugrel Clinical Filing Accepted by China's NMPA
CompanyDrug

C.Q. Pharma’s Prasugrel Clinical Filing Accepted by China’s NMPA

June 25, 2025
BeOne Medicines Launches Ziihera for HER2-High Biliary Tract Cancer in China
CompanyDrug

BeOne Medicines Launches Ziihera for HER2-High Biliary Tract Cancer in China

June 25, 2025
TINGSN Technology Secures RMB 100M in Series B+ Round for 4D Intracardiac Ultrasound R&D
CompanyDeals

TINGSN Technology Secures RMB 100M in Series B+ Round for 4D Intracardiac Ultrasound R&D

June 25, 2025
Bayer and Tsinghua University Renew Strategic Research Pact for Drug Innovation
CompanyDeals

Bayer and Tsinghua University Renew Strategic Research Pact for Drug Innovation

June 25, 2025
Dynamiker Bio's Aspergillus Detection Kit Wins NMPA Marketing Approval
CompanyMedical Device

Dynamiker Bio’s Aspergillus Detection Kit Wins NMPA Marketing Approval

June 25, 2025
GSK Gains FDA Clearance for Benlysta Autoinjector in Pediatric Lupus Nephritis
CompanyDrug

GSK Gains FDA Clearance for Benlysta Autoinjector in Pediatric Lupus Nephritis

June 25, 2025
Medilink Therapeutics' YL201 Wins FDA Breakthrough Therapy Designation for SCLC
CompanyDrug

Medilink Therapeutics’ YL201 Wins FDA Breakthrough Therapy Designation for SCLC

June 25, 2025
Siemens Healthineers Collaborates with MGH to Advance Theranostics Applications
CompanyDeals

Siemens Healthineers Collaborates with MGH to Advance Theranostics Applications

June 25, 2025
1 2 3 4 5 6 7 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up